Paul Hudson

Sanofi SA (NASDAQ: SNY) CEO Paul Hudson said Thursday that the drugmaker is following the standard process of vaccine development with its COVID-19 candidate. What Happened: “We haven’t changed anything in the way we do things, we’ve just accelerated,” Hudson told ...

Despite a global pandemic, Sanofi SA (NASDAQ: SNY) is able to continue its research and development — and it is "essential" to continue showing success in trials, CEO Paul Hudson said on CNBC's "Squawk Box." Sanofi's Momentum In Oncology Sanofi's existing...

France-based global drugmaker Sanofi SA (NYSE: SNY) is working on developing a coronavirus vaccine under the assumption the pandemic will resume "in some form" into 2021, CEO Paul Hudson said Wednesday in a Fox Business interview. Coronavirus Vaccine By Mid-2021? Sanofi's potential...